Identifying Effective and Cost-Conscious Maintenance Daratumumab Dosing

Clinical trial NCT07485647 · RECRUITING

Trial details

NCT number: NCT07485647
Sponsor: Eden Biltibo
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Myeloma

Start date: 2026-04-20
Primary completion: 2028-05-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.